Item 61. FDA Action Plan for Rare Neurodegenerative Diseases | Virpax Pharmaceuticals

Item 61. FDA Action Plan for Rare Neurodegenerative Diseases

Item 61. FDA Action Plan for Rare Neurodegenerative Diseases

admin2022-07-01T17:39:02-04:00July 1st, 2022|

Item 61. FDA Action Plan for Rare Neurodegenerative Diseases

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

© Virpax^® Pharmaceuticals. All Rights Reserved.

© Virpax^® Pharmaceuticals. All Rights Reserved.

Follow @VirpaxPharma

Follow @VirpaxPharma